Exciting Plenary, new scientific sessions, and more in San Francisco

By Joan Guitart, MD
Chair, AAD Scientific Assembly Committee

Joan Guitart, MD

Joan Guitart, MD

At the AAD’s 73rd Annual Meeting, you will see the return of the sessions you have found useful in the past, as well as several updates and additions. With more than 350 sessions from which to choose, it would be impossible to talk about all of them, but I’d like to highlight a few that I’m particularly excited about.

This year’s plenary will feature many noted speakers and topics. The Clarence S. Livingood, MD Award and Lectureship, “Dermatology: Insuring the Future for the Patients We Serve,” will be presented by Bruce E. Wintroub, MD. The unique role of philanthropy and the development of new knowledge — which benefits our patients — will be explored in the context of the future of dermatology. James G. Krueger, MD, PhD, is presenting the Eugene J. Van Scott Award for Innovative Therapy of the Skin and Phillip Frost Leadership Lecture, focusing on the translational revolution for treatment of psoriasis with targeted therapeutics. The Lila and Murray Gruber Memorial Cancer Research Award and Lectureship will feature Antoni Ribas, MD, on “Blocking BRAF and PD-1 to Treat Melanoma.” George Cotsarelis, MD, is scheduled to present the Marion B. Sulzberger, MD Memorial Award and Lectureship, “Hair Loss: From Known Knowns to Unknown Unknowns.” You also will want to stay to “catch” the presentation by Baseball Hall of Fame’s illustrious Johnny Bench, our guest speaker; and a special appearance by Acting Surgeon General Boris D. Lushniak, MD, MPH.

The Academy has scheduled five “late-breaking abstract” sessions (F010, F025, F037, F056, and F071). Our intention is to emphasize advances and new research trends in the field of dermatology. The information and new discoveries that emerge have the potential to impact the practice of our specialty. I also recommend the Hot Topics symposium (S010) in which the most dynamic and important topics selected by registrants of the meeting will be presented. This session provides a platform for cutting-edge information and new therapies in dermatology.

We have great respect for the people who taught us dermatology, and what we learned from them in our training continues to resonate in our daily practice. To pay homage to our masters and revisit their teaching, we have two new symposia, “Pearls From the Masters of Dermatological Surgery” (S004), directed by Christopher Zachary, MD, and “Masters of Dermatology” (S020), directed by William James, MD.

The Scientific Assembly Committee continues to be aware of the concerns and anxiety caused by the changing medical environment in our nation. I would like to recommend two sessions that address the impact of changes to the future of the specialty: “Where Are We Now: Impact of Affordable Care Act on Dermatology” (F062), directed by Clifford Warren Lober, MD, JD; and “The Future of Dermatology: What Changes Are Coming and How Can We Prepare?” (F078), directed by Jack Resneck Jr, MD. And speaking of the future of the specialty, residents will undoubtedly look forward to the new, full-day course “Board Prep for Residents” (C005), led by Jennifer Lucas, MD.

And this, as they say, is just the tip of the iceberg. I hope you will take time to peruse the entire program to find the sessions that are most meaningful to you, as you continue to learn and grow within your field of study and expertise.

Return to index

Top